PMID- 28954185 OWN - NLM STAT- MEDLINE DCOM- 20171208 LR - 20230815 IS - 1469-493X (Electronic) IS - 1361-6137 (Linking) VI - 9 IP - 9 DP - 2017 Sep 27 TI - Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus. PG - CD011469 LID - 10.1002/14651858.CD011469.pub2 [doi] LID - CD011469 AB - BACKGROUND: Many adults with type 2 diabetes mellitus (T2DM) experience a psychosocial burden and mental health problems associated with the disease. Diabetes-related distress (DRD) has distinct effects on self-care behaviours and disease control. Improving DRD in adults with T2DM could enhance psychological well-being, health-related quality of life, self-care abilities and disease control, also reducing depressive symptoms. OBJECTIVES: To assess the effects of psychological interventions for diabetes-related distress in adults with T2DM. SEARCH METHODS: We searched the Cochrane Library, MEDLINE, Embase, PsycINFO, CINAHL, BASE, WHO ICTRP Search Portal and ClinicalTrials.gov. The date of the last search was December 2014 for BASE and 21 September 2016 for all other databases. SELECTION CRITERIA: We included randomised controlled trials (RCTs) on the effects of psychological interventions for DRD in adults (18 years and older) with T2DM. We included trials if they compared different psychological interventions or compared a psychological intervention with usual care. Primary outcomes were DRD, health-related quality of life (HRQoL) and adverse events. Secondary outcomes were self-efficacy, glycosylated haemoglobin A1c (HbA1c), blood pressure, diabetes-related complications, all-cause mortality and socioeconomic effects. DATA COLLECTION AND ANALYSIS: Two review authors independently identified publications for inclusion and extracted data. We classified interventions according to their focus on emotion, cognition or emotion-cognition. We performed random-effects meta-analyses to compute overall estimates. MAIN RESULTS: We identified 30 RCTs with 9177 participants. Sixteen trials were parallel two-arm RCTs, and seven were three-arm parallel trials. There were also seven cluster-randomised trials: two had four arms, and the remaining five had two arms. The median duration of the intervention was six months (range 1 week to 24 months), and the median follow-up period was 12 months (range 0 to 12 months). The trials included a wide spectrum of interventions and were both individual- and group-based.A meta-analysis of all psychological interventions combined versus usual care showed no firm effect on DRD (standardised mean difference (SMD) -0.07; 95% CI -0.16 to 0.03; P = 0.17; 3315 participants; 12 trials; low-quality evidence), HRQoL (SMD 0.01; 95% CI -0.09 to 0.11; P = 0.87; 1932 participants; 5 trials; low-quality evidence), all-cause mortality (11 per 1000 versus 11 per 1000; risk ratio (RR) 1.01; 95% CI 0.17 to 6.03; P = 0.99; 1376 participants; 3 trials; low-quality evidence) or adverse events (17 per 1000 versus 41 per 1000; RR 2.40; 95% CI 0.78 to 7.39; P = 0.13; 438 participants; 3 trials; low-quality evidence). We saw small beneficial effects on self-efficacy and HbA1c at medium-term follow-up (6 to 12 months): on self-efficacy the SMD was 0.15 (95% CI 0.00 to 0.30; P = 0.05; 2675 participants; 6 trials; low-quality evidence) in favour of psychological interventions; on HbA1c there was a mean difference (MD) of -0.14% (95% CI -0.27 to 0.00; P = 0.05; 3165 participants; 11 trials; low-quality evidence) in favour of psychological interventions. Our included trials did not report diabetes-related complications or socioeconomic effects.Many trials were small and were at high risk of bias for incomplete outcome data as well as possible performance and detection biases in the subjective questionnaire-based outcomes assessment, and some appeared to be at risk of selective reporting. There are four trials awaiting further classification. These are parallel RCTs with cognition-focused and emotion-cognition focused interventions. There are another 18 ongoing trials, likely focusing on emotion-cognition or cognition, assessing interventions such as diabetes self-management support, telephone-based cognitive behavioural therapy, stress management and a web application for problem solving in diabetes management. Most of these trials have a community setting and are based in the USA. AUTHORS' CONCLUSIONS: Low-quality evidence showed that none of the psychological interventions would improve DRD more than usual care. Low-quality evidence is available for improved self-efficacy and HbA1c after psychological interventions. This means that we are uncertain about the effects of psychological interventions on these outcomes. However, psychological interventions probably have no substantial adverse events compared to usual care. More high-quality research with emotion-focused programmes, in non-US and non-European settings and in low- and middle-income countries, is needed. FAU - Chew, Boon How AU - Chew BH AD - Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, Utrecht, Netherlands, 3508 GA. FAU - Vos, Rimke C AU - Vos RC FAU - Metzendorf, Maria-Inti AU - Metzendorf MI FAU - Scholten, Rob Jpm AU - Scholten RJ FAU - Rutten, Guy Ehm AU - Rutten GE LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't PT - Review PT - Systematic Review DEP - 20170927 PL - England TA - Cochrane Database Syst Rev JT - The Cochrane database of systematic reviews JID - 100909747 RN - 0 (Glycated Hemoglobin A) SB - IM UOF - doi: 10.1002/14651858.CD011469 MH - Adult MH - Depression/*therapy MH - Diabetes Mellitus, Type 2/blood/*psychology MH - Glycated Hemoglobin/metabolism MH - Humans MH - *Psychotherapy MH - Quality of Life MH - Randomized Controlled Trials as Topic MH - Self Care/psychology MH - Stress, Psychological/*therapy PMC - PMC6483710 COIS- BHC: is receiving living allowances and tuition fees while doing his PhD and this systematic review from Ministry of Education Malaysia and Universiti Putra Malaysia. RV: an unrestricted grant for a study in type 2 diabetes patients on insulin therapy (support of self-managment by triggers) is provided by Sanofi. MIM: none known. RS: none known. GR: received honoraria for consultancy (Novo Nordisk) and a grant for an investigator-initiated study (Sanofi-aventis). EDAT- 2017/09/28 06:00 MHDA- 2017/12/09 06:00 PMCR- 2018/09/27 CRDT- 2017/09/28 06:00 PHST- 2017/09/28 06:00 [pubmed] PHST- 2017/12/09 06:00 [medline] PHST- 2017/09/28 06:00 [entrez] PHST- 2018/09/27 00:00 [pmc-release] AID - CD011469.pub2 [pii] AID - 10.1002/14651858.CD011469.pub2 [doi] PST - epublish SO - Cochrane Database Syst Rev. 2017 Sep 27;9(9):CD011469. doi: 10.1002/14651858.CD011469.pub2.